Malaria, HIV/AIDS, and tuberculosis together kill millions of people each year, and their pathogens are evolving faster than vaccines and drugs can keep up. This Centre will systematically link genetic variation in both pathogens and humans to real-world clinical outcomes—essentially reading the evolutionary arms race between microbes and their hosts to find weak points for intervention. The core problem is that pathogen genomes constantly shift in response to drugs and immune pressure, while human genomes also carry the scars of past epidemics. Until now, these two sides have mostly been studied separately. This project builds the infrastructure to analyse them together, using large-scale epidemiological data from affected populations. If successful, the work could accelerate vaccine design by revealing which pathogen proteins the human immune system actually targets effectively, and flag emerging drug resistance before it becomes widespread. The Centre is translational—it aims to turn genomic patterns into practical guidance for vaccine developers and public health programmes, not just publish papers. For people in malaria- or TB-endemic regions, that could mean vaccines that work longer and drugs that stay effective.
View original technical description
Among the biggest challenges in medical research are (1) to develop effective vaccines against malaria, HIV/AIDS and tuberculosis, which together account for a massive global burden of disease, particularly in the developing world; (2) to combat drug resistance in malaria, HIV/AIDS, tuberculosis, enteric bacteria, invasive bacteria and other pathogens; (3) to combat the emergence of virulent pathogens such as pandemic influenza. Underlying these practical problems in global health is the biological phenomenon of genome diversity. Pathogen genomes are continually evolving in response to human immune pressure and prevailing drug usage; while at the same time infectious diseases are a major force for evolutionary selection of the human genome. Although genome diversity is a large part of the problem in infectious disease, it also offers a scientific route to understanding natural mechanisms of disease and immunity. Epidemiological analysis of the clinical consequences of pathogen genome variation may be highly informative about pathogen mechanisms of virulence, drug resistance and immune evasion. Equally, epidemiological analysis of the clinical consequences of human genome variation may be highly informative about host mechanisms of defence and protective immunity. The aim of this Translational Centre proposal is to develop the scientific environment and technical infrastructure needed to apply genomic epidemiology to practical lessons about disease prevention ? particularly about drug resistance and vaccine development.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know